Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
Conditions
Interventions
Intervention1: Oral Ivermectin alone
and oral ivermectin with topical ivermectin and topical permethrin: Group A B and C will be informed to take a stat dose of Oral Ivermectin 200microgram/kg on 1st
Sponsors
SELF
Dr K Venkateshwaran
Eligibility
Inclusion criteria
Inclusion criteria: New patients of scabies age between 5 to 60 years History of involvement of family members or similar symptoms in contacts Patient with history of nocturnal itching Patients who were willing to participate and give written informed consent
Exclusion criteria
Exclusion criteria: Age below 5 years, patients more than 60 years Pregnant women and lactating women Patients not willing to participate and for follow-up Prior use of topical or systemic scabicide in last 4 weeks Patients on radiotherapy, steroids or other immunosuppressive drugs for any systemic or cutaneous indication Hypersensitivity to permethrin or ivermectin Participants with any other associated skin disease, which would alter the picture of scabies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete resolution of active scabetic lesions and Absence of new lesionsTimepoint: Two to Four weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in pruritus, time to symptom relief, adverse effects, and recurrence ratesTimepoint: Two to Four weeks | — |
Countries
India
Contacts
Public ContactDr K Venkateshwaran
Vinayaka Missions Medical College and Hospitals
Outcome results
None listed